ML17265A046

Northwest Medical Isotopes, LLC Response to U.S. Nuclear Regulatory Commission Request for Additional Information Regarding Application for Construction Permit

ML17265A046
Person / Time
Site:	Northwest Medical Isotopes
Issue date:	09/19/2017
From:	Haass C Northwest Medical Isotopes
To:	Michael Balazik Document Control Desk, Division of Policy and Rulemaking
Shared Package
ML17265A039	List: ML17265A046 ML17265A047 ML17265A048
References
NWMI-LTR-2017-014, TAC MF6138
Download: ML17265A046 (2)

Text

.:;.-.~*.. NWMI

......... ~=*

o 0....... A NOllllfll'IEST MEDICAL ISOTOPES U.S. Nuclear Regulatory Commission ATTN: Document Control Desk 11555 Rockville Pike Washington, DC 20555 Mr. Michael Balazik:

Research and Test Reactors Branch A Division of Policy and Rulemaking Office of Nuclear Reactor Regulation September 19, 2017 NWMI-LTR-2017-014 RE:

Northwest Medical Isotopes, LLC Response to U.S. Nuclear Regulatory Commission Request for Additional Information Regarding Application for Construction Permit (TAC No. MF6138), Docket No. 50-609, dated September 18, 2017

References:

1. Email from Michael Balazik, U.S. Nuclear Regulatory Commission, to Carolyn Haass, Northwest Medical Isotopes, LLC, dated September 18, 2017, "Draft RAis Criticality"

2. Northwest Medical Isotopes, LLC Letter NWMI-LTR-2017-012 to U.S. Nuclear Regulatory Commission, dated September 8, 2017, "Docket No. 50-609, Northwest Medical Isotopes, LLC, Transmittal of Revision 3 of Chapters 1.0 through 18.0 ofNWMI-2013-021, Construction Permit Application for Radioisotope Production"

Dear Mr. Balazik:

Northwest Medical Isotopes, LLC (NWMI) is providing the attached response (Attachment 1) to the U.S. Nuclear Regulatory Commission request for additional information dated September 18, 2017.

NWMI is submitting this response to the NRC in accordance with 10 CFR 50.30(b ), "Oath or Affirmation," and 10 CFR 50.4, "Written Communications."

I solemnly declare and affirm that the foregoing information is true and correct under the penalty of perjury; executed on September 19, 2017.

Northwest Medical Isotopes, LLC I 815 NW 9th Ave, Suite 256 I Corvallis, OR 97330

Mr. Michael Balazik page2 If you have questions, I can be reached at (509) 430-6921 or carolyn.haass@nwmedicalisotopes.com.

Sincerely, c~*e_f/~

Carolyn C. Haass Chief Operating Officer

Enclosures:

Attachment 1 cc:

Mr. Alexander Adams Research and Test Reactors Branch A Office of Nuclear Reactor Regulation 11.*

L,.,;*

l.*

':* *.*.